Walgreens Boots Alliance (NASDAQ:WBA) Shares Down 2.5% Following Analyst Downgrade (2024)

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) were down 2.5% during trading on Wednesday after UBS Group lowered their price target on the stock from $17.00 to $12.00. UBS Group currently has a neutral rating on the stock. Walgreens Boots Alliance traded as low as $11.26 and last traded at $11.28. Approximately 8,255,778 shares traded hands during mid-day trading, a decline of 43% from the average daily volume of 14,606,245 shares. The stock had previously closed at $11.57.

Several other brokerages also recently issued reports on WBA. Evercore ISI cut their price objective on Walgreens Boots Alliance from $17.00 to $10.00 and set an "in-line" rating for the company in a research report on Friday, June 28th. Bank of America restated an "underperform" rating and set a $11.00 target price (down previously from $22.00) on shares of Walgreens Boots Alliance in a research report on Friday, June 28th. Deutsche Bank Aktiengesellschaft cut their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a "hold" rating on the stock in a research note on Wednesday, April 3rd. Truist Financial cut their price target on Walgreens Boots Alliance from $20.00 to $13.00 and set a "hold" rating on the stock in a research note on Friday, June 28th. Finally, Barclays cut their price target on Walgreens Boots Alliance from $21.00 to $19.00 and set an "underweight" rating on the stock in a research note on Monday, June 24th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $17.71.

Get Our Latest Stock Analysis on WBA

Ad Monument Traders AllianceAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.See here to see the full details.

Insider Buying and Selling

In other news, Director Inderpal S. Bhandari acquired 3,000 shares of the firm's stock in a transaction that occurred on Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 17.40% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of WBA. Highlander Capital Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Pineridge Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Venturi Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator's stock valued at $28,000 after buying an additional 981 shares during the last quarter. Rocky Mountain Advisers LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $30,000. Finally, Quest Partners LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $30,000. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Performance

The company has a market capitalization of $9.58 billion, a price-to-earnings ratio of -1.67, a PEG ratio of 0.82 and a beta of 0.72. The stock has a 50-day moving average price of $16.23 and a 200-day moving average price of $19.95. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). The firm had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business's revenue for the quarter was up 2.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.00 earnings per share. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were issued a dividend of $0.25 per share. The ex-dividend date was Monday, May 20th. This represents a $1.00 annualized dividend and a yield of 9.01%. Walgreens Boots Alliance's payout ratio is currently -14.84%.

About Walgreens Boots Alliance

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

  • Five stocks we like better than Walgreens Boots Alliance
  • Quiet Period Expirations Explained
  • AbbVie Stock: A Perfect Dip for Investors to Buy
  • Best ESG Stocks: 11 Best Stocks for ESG Investing
  • Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
  • What is a Stock Market Index and How Do You Use Them?
  • GitLab Stock Rebounds: The Inside Story of Its Comeback

→ This student turned $1,300 into $45,000 in just 4 Months! (From Monument Traders Alliance) (Ad)Walgreens Boots Alliance (NASDAQ:WBA) Shares Down 2.5% Following Analyst Downgrade (3)

Should you invest $1,000 in Walgreens Boots Alliance right now?

Before you consider Walgreens Boots Alliance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.

While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Walgreens Boots Alliance (NASDAQ:WBA) Shares Down 2.5% Following Analyst Downgrade (4)

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Walgreens Boots Alliance (NASDAQ:WBA)  Shares Down 2.5%  Following Analyst Downgrade (2024)

FAQs

Is Walgreens Boots Alliance stock a buy? ›

Is WBA a Buy, Sell or Hold? Walgreens Boots Alliance has a consensus rating of Hold which is based on 2 buy ratings, 7 hold ratings and 3 sell ratings.

What is the future of WBA stock? ›

Based on short-term price targets offered by 15 analysts, the average price target for Walgreens Boots Alliance comes to $14.80. The forecasts range from a low of $9.00 to a high of $22.00. The average price target represents an increase of 36.78% from the last closing price of $10.82.

What is the difference between Walgreens and Walgreens Boots Alliance? ›

Walgreens Boots Alliance, Inc.

(WBA) is an American multinational holding company headquartered in Deerfield, Illinois, which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies.

Who are the largest shareholders of Walgreens Boots Alliance? ›

Largest shareholders include Vanguard Group Inc, BlackRock Inc., State Street Corp, Capital World Investors, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, Geode Capital Management, Llc, VFINX - Vanguard 500 Index Fund Investor Shares, Invesco Ltd., Invesco Qqq Trust, Series 1, and VIMSX - Vanguard Mid ...

What is the stock price forecast for WBA in 2025? ›

According to analysts, WBA price target is 14.91 USD with a max estimate of 26.00 USD and a min estimate of 9.00 USD.

What is the highest Walgreens stock has ever been? ›

The latest closing stock price for Walgreens as of July 08, 2024 is 10.82.
  • The all-time high Walgreens stock closing price was 70.02 on August 05, 2015.
  • The Walgreens 52-week high stock price is 31.32, which is 189.5% above the current share price.

What does the future look like for Walgreens? ›

Expect a leaner, smaller footprint

One of the things that's likely to happen over the next decade is that Walgreens becomes smaller in size. The company has a lot of physical store locations, but that means a higher level of staffing needs and resources. It also comes with more costs and challenges.

Does WBA pay a monthly dividend? ›

Walgreens Boots Alliance, Inc. ( WBA ) pays dividends on a quarterly basis. The next dividend payment is planned on June 12, 2024 .

What is Walgreens stock price forecast for 2024? ›

Walgreens Boots Stock Price Forecast 2024-2025

The forecasted Walgreens Boots price at the end of 2024 is $13.68 - and the year to year change -48%. The rise from today to year-end: +27%.

Why is WBA stock falling? ›

Not only did Walgreens post downbeat earnings, it lowered its full-year outlook due to a challenging consumer environment. This did not bode well with the investors, and WBA stock plunged over 20% in the early hours of trading on Thursday, June 27.

How much debt does Walgreens Boots Alliance have? ›

Total debt on the balance sheet as of May 2024 : $32.67 B

According to Walgreens Boots Alliance's latest financial reports the company's total debt is $32.67 B. A company's total debt is the sum of all current and non-current debts.

Does Walmart own Walgreens? ›

Does Walmart own Walgreen's stores? No, Walmart does not have any relationship with Walgreens. Sam's Club and Walmart are connected to the same people, and were started by Sam Walton. Walgreen's is a separate company.

Who owns the most WBA stock? ›

According to the latest TipRanks data, approximately 35.94% of Walgreens Boots Alliance (WBA) stock is held by retail investors. Who owns the most shares of Walgreens Boots Alliance (WBA)? Vanguard owns the most shares of Walgreens Boots Alliance (WBA).

What brands are under the Walgreens Boots Alliance? ›

WBA employs more than 331,000 people and has a presence in eight countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico.

What is the dividend growth rate for Walgreens Boots Alliance? ›

During the past 12 months, Walgreens Boots Alliance's average Dividends Per Share Growth Rate was -24.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 1.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 3.00% per year.

Is BOOT a good stock to buy? ›

Out of 8 analysts, 6 (75%) are recommending BOOT as a Strong Buy, 1 (12.5%) are recommending BOOT as a Buy, 1 (12.5%) are recommending BOOT as a Hold, 0 (0%) are recommending BOOT as a Sell, and 0 (0%) are recommending BOOT as a Strong Sell.

What is the target price for Walgreens Boots Alliance? ›

Snapshot
Average RecommendationHold
Average Target Price13.14
Number Of Ratings20
FY Report Date8/2024
Last Quarter's Earnings0.63
6 more rows

Is VFC a good stock to buy? ›

V.F stock has received a consensus rating of hold. The average rating score is and is based on 39 buy ratings, 47 hold ratings, and 10 sell ratings.

Is Alliance Pharma a buy or sell? ›

Alliance Pharma PLC has 106.67% upside potential, based on the analysts' average price target. Is Alliance Pharma PLC a Buy, Sell or Hold? Alliance Pharma PLC has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.

References

Top Articles
Latest Posts
Article information

Author: Corie Satterfield

Last Updated:

Views: 5912

Rating: 4.1 / 5 (62 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Corie Satterfield

Birthday: 1992-08-19

Address: 850 Benjamin Bridge, Dickinsonchester, CO 68572-0542

Phone: +26813599986666

Job: Sales Manager

Hobby: Table tennis, Soapmaking, Flower arranging, amateur radio, Rock climbing, scrapbook, Horseback riding

Introduction: My name is Corie Satterfield, I am a fancy, perfect, spotless, quaint, fantastic, funny, lucky person who loves writing and wants to share my knowledge and understanding with you.